SI
TCON

SII Investments’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

SII Investments’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-128
Closed -$61K – 641
2017
Q2 		$61K Hold
128
– – ﹤0.01% 581
2017
Q1 		$92K Sell
128
-19
-13% -$17K 0.01% 595
2016
Q4 		$144K Sell
147
-32
-18% -$36.6K 0.01% 564
2016
Q3 		$238K Buy
+179
New +$202K 0.02% 505

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SII Investments's TCON Position: Q3 2017 in Review

SII Investments sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2017, closing a stake of 128 shares — an estimated $61K sold.

SII Investments first reported a position in TCON in Q3 2016 and held it in 4 quarters. The position peaked at $238K in Q3 2016. 26 funds tracked by Wall St. Rank hold TCON as of Q3 2017.

  • SII Investments reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • SII Investments sold 128 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2017, an estimated $61K.
  • SII Investments first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2016 and held it in 4 quarters.
  • SII Investments's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $238K in Q3 2016.
  • 26 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2017.

Based on SII Investments's 13F filing for Q3 2017, filed 13 Nov 2017.